Innovation Pharmaceuticals Inc. (IPIX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
+0.0001 (50.00%)
At close: Oct 20, 2026
Innovation Pharmaceuticals Company Description
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.
It offers Brilacidin, a immunomodulatory drug candidate with anti-inflammatory and antimicrobial therapeutic applications.
The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017.
Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.
Innovation Pharmaceuticals Inc.
| Country | United States |
| Founded | 2005 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Leo Ehrlich |
Contact Details
Address: 301 Edgewater Place Wakefield, Massachusetts 01880 United States | |
| Phone | 978 921 4125 |
| Website | ipharminc.com |
Stock Details
| Ticker Symbol | IPIX |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| ISIN Number | US45782D1000 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Leo Ehrlich CPA | Chairman, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer and Secretary |
| Jane Harness M.S., MP | Senior Vice President of Clinical Sciences and Portfolio Management |
| Jim Boeheim | Business Advisor |